Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Transfusion

High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZachary M. AviganADAjoy DiasLDLaura E. Dodge

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Avigan et al. (2024) studied this question.

synapsesocial.com/papers/68e6c5cab6db643587643dddhttps://doi.org/10.1111/trf.17864
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CD34 <sup>+</sup> cell dose - Predictors and effect on patient outcome in hematopoietic stem cell transplant2026 · 1 citations
  2. 2Impact of CD34+ cell dose on outcomes of haploidentical peripheral blood stem cell transplantation in acute leukemia2025
  3. 3Effects of CD34<sup>+</sup> cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation2024 · 5 citations
  4. 4To determine correlation of CD3+ T cells infusion dose with Acute Graft Versus Host Disease (GVHD) in patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).2024
  5. 5Impact CD34+ cell doses and allograft composition on acute graft-versus-host disease: A single-center prospective cohort study2025